MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Zimmer Biomet Holdings Company Profile (NYSE:ZBH)

Consensus Ratings for Zimmer Biomet Holdings (NYSE:ZBH) (?)
Ratings Breakdown: 1 Sell Rating(s), 5 Hold Rating(s), 16 Buy Rating(s)
Consensus Rating:Buy (Score: 2.68)
Consensus Price Target: $123.95 (4.03% upside)

Analysts' Ratings History for Zimmer Biomet Holdings (NYSE:ZBH)
Show:
DateFirmActionRatingPrice TargetActions
6/21/2016Piper JaffrayReiterated RatingOverweight$125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Needham & Company LLCReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Canaccord GenuityReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Leerink SwannReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Morgan StanleyReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016GuggenheimInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016RBC CapitalReiterated RatingBuy$132.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Jefferies GroupReiterated RatingBuy$135.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/25/2016ArgusUpgradeHold -> Buy$140.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2016Sterne Agee CRTReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016OppenheimerReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/30/2016BarclaysReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2016Goldman SachsLower Price Target$113.00 -> $111.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/20/2016Bank of AmericaInitiated CoverageBuy$127.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/17/2016NomuraInitiated CoverageBuy$123.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/31/2016William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/29/2016Northland SecuritiesLower Price Target$109.00 -> $105.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/27/2016JMP SecuritiesBoost Price TargetMarket Outperform$118.00 -> $125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/12/2015Citigroup Inc.Initiated CoverageSell$92.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/30/2015Brean CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2015BMO Capital MarketsLower Price Target$132.00 -> $120.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/9/2015Credit SuisseInitiated CoverageOutperform$107.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/29/2015Deutsche BankReiterated RatingHold$114.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/30/2015Robert W. BairdUpgradeNeutral -> Outperform$110.00 -> $125.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/9/2015SunTrustDowngradeBuy -> NeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/5/2015JPMorgan Chase & Co.UpgradeNeutral -> Overweight$120.00 -> $136.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2014Cantor FitzgeraldBoost Price Target$117.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for Zimmer Biomet Holdings (NYSE:ZBH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/28/2016        
4/28/2016Q116$1.93$2.00$1.88 billion$1.90 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/28/2016Q415$2.04$2.09$1.96 billion$1.98 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/29/2015Q315$1.56$1.64$1.76 billion$1.76 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/30/2015Q115$1.54$1.58$1.15 billion$1.13 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/29/2015Q414$1.71$0.91$1.25 billion$1.22 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/23/2014Q314$1.00$0.96$1.10 billion$1.11 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/24/2014Q214$1.49$1.49$1.21 billion$1.18 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/24/2014Q114$1.47$1.50$1.18 billion$1.16 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2014Q114$1.62$1.36$1.22 billion$1.24 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/24/2013Q313$1.24$1.25$1.06 billion$1.07 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/25/2013Q2 2013$1.44$1.43$1.15 billion$1.17 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/25/2013Q1 2013$1.40$1.41$1.14 billion$1.14 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/31/2013Q4 2012$1.49$1.51$1.17 billion$1.18 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/25/2012$1.13$1.15ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/26/2012$1.32$1.34ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/26/2012$1.30$1.30ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/26/2012$1.34$1.36ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2011$1.03$1.04ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/27/2011$1.19$1.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2011$1.12$1.19ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
1/27/2011$1.19$1.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Zimmer Biomet Holdings (NYSE:ZBH)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20165$1.91$1.97$1.93
Q2 20166$1.96$2.14$2.00
Q3 20165$1.77$1.88$1.82
Q4 20165$1.98$2.19$2.11
Q1 20171$2.25$2.25$2.25
Q2 20171$2.16$2.16$2.16
Q3 20171$2.04$2.04$2.04
Q4 20171$2.40$2.40$2.40
(Data provided by Zacks Investment Research)
Current Dividend Information for Zimmer Biomet Holdings (NYSE:ZBH)
Annual Dividend:$0.00
Dividend Yield:0.00%
Payout Ratio:NaN
Dividend Growth:0.00% (3 Year Average)

Dividend History for Zimmer Biomet Holdings (NYSE:ZBH)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/23/2016quarterly$0.246/22/20166/24/20167/29/2016Tweet This Announcement  Share This Announcement on StockTwits
2/24/2016quarterly$0.240.99%3/29/20163/31/20164/29/2016Tweet This Announcement  Share This Announcement on StockTwits
12/14/2015quarterly$0.220.87%12/29/201512/31/20151/29/2016Tweet This Announcement  Share This Announcement on StockTwits
8/24/2015quarterly$0.220.9%9/28/20159/30/201510/30/2015Tweet This Announcement  Share This Announcement on StockTwits
5/5/2015quarterly$0.220.8%5/13/20155/15/20157/14/2015Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015quarterly$0.220.73%3/4/20153/6/20154/24/2015Tweet This Announcement  Share This Announcement on StockTwits
12/15/2014quarterly$0.220.81%12/24/201412/29/20141/30/2015Tweet This Announcement  Share This Announcement on StockTwits
8/26/2014quarterly$0.220.87%9/24/20149/26/201410/31/2014Tweet This Announcement  Share This Announcement on StockTwits
5/23/2014quarterly$0.220.86%6/25/20146/27/20147/25/2014Tweet This Announcement  Share This Announcement on StockTwits
3/5/2014quarterly$0.220.9%3/26/20143/28/20144/25/2014Tweet This Announcement  Share This Announcement on StockTwits
12/16/2013quarterly$0.200.88%12/24/201312/27/20131/31/2014Tweet This Announcement  Share This Announcement on StockTwits
9/9/2013quarterly$0.200.99%9/25/20139/27/201310/25/2013Tweet This Announcement  Share This Announcement on StockTwits
6/14/2013quarterly$0.201.03%6/26/20136/28/20137/26/2013Tweet This Announcement  Share This Announcement on StockTwits
3/8/2013quarterly$0.201.06%3/26/20133/29/20134/26/2013Tweet This Announcement  Share This Announcement on StockTwits
12/14/2012quarterly$0.181.06%12/24/201212/27/20121/25/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Zimmer Biomet Holdings (NYSE:ZBH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/14/2016Tony W CollinsCAOSell3,611$116.43$420,428.73View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/9/2016Stuart G KleopferInsiderSell11,000$119.45$1,313,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2016Daniel P FlorinCFOSell10,000$114.98$1,149,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/12/2016Daniel P FlorinCFOSell12,000$110.00$1,320,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/21/2016David C DvorakCEOSell1,540$104.16$160,406.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2016Blackstone Capital Partners VMajor ShareholderSell7,351,708$95.91$705,102,314.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2016David C. DvorakCEOSell44,661$102.46$4,575,966.06View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/2/2015David A. Jr. NolaninsiderSell3,435$102.62$352,499.70View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/30/2015Adam Rudolph JohnsonInsiderSell30,600$110.34$3,376,404.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/29/2015Daniel E WilliamsonInsiderSell16,000$110.98$1,775,680.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/29/2015Daniel P FlorinCFOSell5,000$107.00$535,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/17/2015David C DvorakCEOSell1,300$115.55$150,215.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/5/2014David C DvorakCEOSell48,703$115.00$5,600,845.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014Chad F PhippsVPSell5,000$112.00$560,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2014Katarzyna Mazur-HofsaessInsiderSell28,253$110.01$3,108,112.53View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/9/2014Stephen Hong Liang OoiInsiderSell40,768$102.78$4,190,135.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/26/2014James T CrinesCFOSell40,768$101.00$4,117,568.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/8/2014Jeffery MccaulleyInsiderSell21,286$96.00$2,043,456.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/7/2014Chad PhippsVPSell7,000$95.00$665,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/20/2013Jeffery MccaulleyInsiderSell21,286$93.00$1,979,598.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/3/2013Jeffery MccaulleyInsiderSell2,713$90.12$244,495.56View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/15/2013Derek DavisCAOSell3,500$90.20$315,700.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2013Chad PhippsVPSell7,800$90.00$702,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2013David DvorakCEOSell64,763$90.00$5,828,670.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2013Jeffery MccaulleyInsiderSell21,285$90.00$1,915,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/13/2013Katarzyna Mazur-HofsaessInsiderSell4,890$81.38$397,948.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013James T CrinesCFOSell46,200$84.56$3,906,672.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/1/2013Stephen Hong Liang OoiInsiderSell38,500$84.27$3,244,395.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2013Derek M DavisCAOSell3,725$83.78$312,080.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/29/2013Jeffery A MccaulleyInsiderSell112,255$83.40$9,362,067.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/19/2013Chad F PhippsVPSell6,000$83.00$498,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2013Chad F PhippsVPSell5,000$77.26$386,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/30/2013James T CrinesCFOSell25,000$76.08$1,902,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/30/2013Jeffery A MccaulleyInsiderSell10,000$76.08$760,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013Derek M DavisCAOSell21,864$72.53$1,585,795.92View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/4/2013Jeffery A MccaulleyInsiderSell12,000$73.60$883,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Zimmer Biomet Holdings (NYSE:ZBH)
DateHeadline
06/29/16 07:20 PMZimmer Biomet Holdings Incorporated (NYSE:ZBH) Shorts Decreased by 5.91% After Short Covering - Engelwood Daily
06/29/16 07:20 PMInstitutional Investor Sentiment About Zimmer Holdings Inc (NYSE:ZBH) Increased - Press Telegraph
06/29/16 07:20 PMZimmer Biomet Holdings Inc (NYSE:ZBH): Taking a look at the Consensus Estimates from Analysts - Telanagana Press
06/29/16 07:20 PMRecently Issued Stock Ratings For Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Fiscal Standard
06/28/16 04:28 AMCovering the Bases on Zimmer Biomet Holdings Inc (NYSE:ZBH): Where is the Stock Going? - Press Telegraph
06/28/16 04:28 AMZimmer Biomet (ZBH) Receives Early HSR Act Termination in Proposed LDR Holding Deal - StreetInsider.com
06/27/16 07:09 PMZimmer Biomet (ZBH) Receives Early HSR Act Termination in Proposed LDR Holding Deal
06/27/16 03:51 PMJun 27, 2016 Zimmer Biomet Celebrates Four Decades of Excellence with the 40th Anniversary of the Oxford® Partial Knee System - [at noodls] - WARSAW, Ind., June 27, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, is pleased to announce the 40th anniversary of the Oxford Partial ...
06/27/16 03:30 PMZimmer Biomet Celebrates Four Decades of Excellence with the 40th Anniversary of the Oxford® Partial Knee System - [PR Newswire] - WARSAW, Ind., June 27, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, is pleased to announce the 40th anniversary of the Oxford® Partial Knee System, the most widely used and clinically proven1 partial knee replacement system in the world. A partial knee replacement is a treatment for osteoarthritis (OA) in which one of the knee's three compartments is replaced, whereas with total knee replacement, all three of the knee's compartments are replaced. Studies have shown partial knee replacement patients have better range of motion2-3, shorter hospital stays with a rapid recovery protocol2, and fewer and less severe complications4, compared to total knee replacement patients. "When the ligaments in the knee are present and can be preserved, a partial knee replacement is the optimal choice to restore joint function and normal mobility, while enhancing the speed and comfort of a patient's recovery," said Professor Andrew Price, MA D.Phil FRCS, Consultant Orthopaedic Surgeon and Professor of Musculoskeletal Science at the Nuffield Department of Orthopaedic Surgery at Oxford University, in the United Kingdom.
06/27/16 09:42 AMZimmer Biomet Holdings, Inc. breached its 50 day moving average in a Bearish Manner : ZBH-US : June 27, 2016 -
06/27/16 07:21 AMJun 27, 2016 Zimmer Biomet Announces Early Termination of HSR Waiting Period - [at noodls] - WARSAW, Ind., June 27, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ('Zimmer Biomet') today announced the early termination of the waiting period under the Hart-Scott-Rodino Antitrust ...
06/27/16 04:01 AMShare Update and Earnings Review for Zimmer Biomet Holdings Inc (NYSE:ZBH) - Press Telegraph
06/23/16 09:56 AMZimmer Biomet Holdings (NYSE:ZBH) Analyst Rating Consensus - Trade Calls
06/22/16 07:22 PMWhat Do Analysts Recommend for Zimmer Biomet Holdings?
06/21/16 04:20 AMEx-Dividend Reminder: Convergys, Zimmer Biomet Holdings and DENTSPLY SIRONA - Forbes
06/17/16 11:32 AMZimmer Biomet Holdings, Inc. – Value Analysis (NYSE:ZBH) : June 17, 2016 -
06/16/16 07:36 PMAnalyst Overview on These Stocks: Zimmer Biomet Holdings, Inc. (NYSE:ZBH), McKesson Corporation (NYSE:MCK) - Beacon Chronicle
06/16/16 03:59 PMJun 16, 2016 Zimmer Biomet Announces Enhancements to Joint Reconstruction Portfolio for the Treatment of Patients with Significant Bone Loss - [at noodls] - WARSAW, Ind., June 16, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the global commercial launch of new enhancements ...
06/16/16 03:44 PMZIMMER BIOMET HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD Disclosure -
06/16/16 03:30 PMZimmer Biomet Announces Enhancements to Joint Reconstruction Portfolio for the Treatment of Patients with Significant Bone Loss - [PR Newswire] - WARSAW, Ind., June 16, 2016 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced the global commercial launch of new enhancements ...
06/16/16 11:23 AMInvestors Snag ZBH Even Cheaper Than Its Secondary Stock Offering - Looking back to 2 days ago, Zimmer Biomet Holdings Inc (NYSE: ZBH) priced a 11,116,533 share secondary stock offering at $115.85 per share. Buyers in that offering made a considerable investment into the company, expecting that their investment would go up over the course of time. In trading on Thursday, bargain hunters could buy shares of ZBH and achieve a cost basis even cheaper than those buyers, with shares changing hands as low as $114.95 per share.
06/15/16 07:16 PMCowen Downgrades LDR Holding Following Zimmer Biomet Acquisition - Benzinga
06/15/16 07:16 PMStocks inside Analysts Limelight: Zimmer Biomet Holdings, Inc. (NYSE:ZBH) , Sarepta Therapeutics, Inc. (NASDAQ ... - Street Updates
06/15/16 02:21 PMCowen Downgrades LDR Holding Following Zimmer Biomet Acquisition - Cowen downgraded LDR Holding Corp (NASDAQ: LDRH) to Market Perform from Outperform following its deal to be bought by Zimmer Biomet Holdings Inc (NYSE: ZBH) for $37 a share. "With shares of LDRH trading near the acquisition price, we are downgrading shares of LDRH to Market Perform and raising our price target to $37/sh, the acquisition price by ZBH," analyst Joshua Jennings wrote in a note. Further, Jennings isn't expecting any competing bids and doesn't see any ...Full story available on Benzinga.com
06/15/16 07:45 AMZimmer Biomet Holdings, Inc. breached its 50 day moving average in a Bearish Manner : ZBH-US : June 15, 2016 -
06/14/16 06:58 PMAnalyst Earnings Report: Zimmer Biomet Holdings, Inc. (NYSE:ZBH), LDR Holding Corporation (NASDAQ:LDRH) - Beacon Chronicle
06/13/16 06:50 PMEarnings Expectations of the Stocks: Zimmer Biomet Holdings, Inc. (NYSE:ZBH), Bunge Limited (NYSE:BG) - Beacon Chronicle
06/13/16 06:50 PMZimmer Biomet Holdings (ZBH): Today's Post-Market Laggard - TheStreet.com
06/13/16 09:50 AMStryker, Halo to get second chance at enhanced patent damages -
06/10/16 04:03 PMZIMMER BIOMET HOLDINGS, INC. Files SEC form 8-K/A, Regulation FD Disclosure, Financial Statements and Exhibits -
06/09/16 10:20 AMINVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation Into the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH - [PR Newswire] - NEW YORK, June 9, 2016 /PRNewswire/ -- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased LDR Holding Corporation (NASDAQ: LDRH) stock prior to ...
06/09/16 09:44 AMRival Offer for LDR Is Unlikely, but Never Say Never -
06/08/16 07:14 PMLDR (LDRH) ALERT: Johnson & Weaver, LLP Launches an Investigation into the Fairness of Price and Process in Proposed Sale of LDR Holding Corporation; Is $37.00 a Fair Price? - [PR Newswire] - SAN DIEGO, June 8, 2016 /PRNewswire/ -- Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of LDR Holding Corporation (NASDAQ: LDRH) breached ...
06/07/16 05:05 PMMedical-device company will buy rival for $1 billion, growing Colorado-based division -
06/07/16 04:20 PMZIMMER BIOMET HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and -
06/07/16 10:23 AMZIMMER BIOMET HOLDINGS INC. (NYSE:ZBH) Financial Condition Compared to S&P 500 - CML News
06/07/16 10:23 AMWater-Logged And Getting Wetter: Zimmer Biomet Holdings (ZBH) - TheStreet.com
06/07/16 10:19 AMSHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation Concerning the Fairness of the Sale of LDR Holding Corporation to Zimmer Biomet Holdings, Inc. - LDRH - [Accesswire] - NEW YORK, NY / ACCESSWIRE / June 7, 2016 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased LDR Holding Corporation (NASDAQ: LDRH) stock prior ...
06/07/16 10:07 AMJim Cramer: Zimmer-LDR Deal Is Great -
06/07/16 09:42 AMLDR (LDRH) Stock Skyrockets on $1 billion Zimmer Biomet Deal -
06/07/16 08:53 AMZimmer Biomet to Buy Fellow Medical Device Maker LDR Holding - Wall Street Journal - Zimmer Biomet to Buy Fellow Medical Device Maker LDR HoldingWall Street JournalZimmer Biomet Holdings Inc. said Tuesday it would buy fellow medical device maker LDR Holding Corp. for $1.07 billion, a move to beef up its presence in the global spine market. Zimmer Biomet said it would conduct a tender offer for all shares ...Zimmer Biomet To Acquire LDR To Enhance Innovation And Growth Of Spine BusinessPR Newswire (press release)12 Stocks Moving In Tuesday's Pre-Market SessionBenzingaZimmer Biomet buys spine surgery device firm LDR for $1BSeeking AlphaDaily Mail -RTT News -Sonoran Weekly Review -Finance Dailyall 18 news articles »
06/07/16 07:34 AMZimmer to buy LDR in $1 billion deal to beef up spine offerings - (Reuters) - Zimmer Biomet Holdings Inc , a maker of orthopedic reconstructive products, said it would buy LDR Holding Corp in a deal valued at about $1 billion to expand its presence in the spine...
06/07/16 06:51 AMZimmer to buy LDR in $1 bln deal to beef up spine offerings - June 7 (Reuters) - Zimmer Biomet Holdings Inc, a maker of orthopedic reconstructive products, said it would buy LDR Holding Corp in a deal valued at about $1 billion to expand its presence in the...
06/06/16 07:37 PMTraders Targeted Movers: Zimmer Biomet Holdings, Inc. (NYSE:ZBH) , Alder BioPharmaceuticals, Inc. (NASDAQ:ALDR) - Street Updates
06/03/16 08:12 PMAnalysts View Favorably Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Stock Tick Tock
06/02/16 08:01 PMZimmer Biomet Holdings Inc (NYSE:ZBH) Stock Update & Estimates - Stock Tick Tock - Zimmer Biomet Holdings Inc (NYSE:ZBH) Stock Update & EstimatesStock Tick TockThe consensus on Wall Street is expecting Zimmer Biomet Holdings Inc (NYSE:ZBH) to post earnings of $1.96 per share when the firm next reports it's fiscal quarterly results. According to the latest information available the report will likely be issued ...and more »
06/02/16 10:48 AMOverview of Price Moves: Antares Pharma, Inc. (NASDAQ:ATRS) , Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Street Updates - Is storiesOverview of Price Moves: Antares Pharma, Inc. (NASDAQ:ATRS) , Zimmer Biomet Holdings, Inc. (NYSE:ZBH)Street UpdatesIn the past trading session, Zimmer Biomet Holdings, Inc. (NYSE:ZBH) ended trading session higher at $122.15 with +0.03%. The company traded a volume of 952.99 thousand shares as comparison to average volume of 1.33 million shares. During the 52 ...Zimmer Biomet Holdings Inc(NYSE:ZBH) Declares Dividend of $0.2400.Trade CallsZimmer Biomet Holdings, Inc. (NYSE:ZBH) Updated Broker RatingsRisers & FallersReliable stocks in today's share market: Zimmer Biomet Holdings, Inc. (NYSE:ZBH)The News JournalZergwatch -Stock Tick Tock -Is storiesall 13 news articles »
06/01/16 08:13 PMEarnings Overview: Illinois Tool Works Inc. (NYSE:ITW), Zimmer Biomet Holdings, Inc. (NYSE:ZBH) - Beacon Chronicle - Earnings Overview: Illinois Tool Works Inc. (NYSE:ITW), Zimmer Biomet Holdings, Inc. (NYSE:ZBH)Beacon ChronicleLast Trade: The Company closed its last session at $106.03 with the gain of 0.66%. The market capitalization of the company is $38.08 Billion, with the average Volume of 1.42 Million. The stock currently has its 52-Week High range of $106.19 and 52 ...and more »
05/31/16 10:15 AMShare Rating Focus on Zimmer Biomet Holdings Inc (NYSE:ZBH) - HNN - Share Rating Focus on Zimmer Biomet Holdings Inc (NYSE:ZBH)HNNPresently, Wall Street analysts have given a consensus stock rating of 1.64 on shares of Zimmer Biomet Holdings Inc (NYSE:ZBH). Covering analysts will typically provide Buy, Sell, or Hold recommendations based on extensive research. This consensus ...and more »
05/31/16 10:15 AMZimmer Biomet Holdings Inc(NYSE:ZBH) Declares Dividend of $0.2400. - Trade Calls - Is storiesZimmer Biomet Holdings Inc(NYSE:ZBH) Declares Dividend of $0.2400.Trade CallsZimmer Biomet Holdings Inc (NYSE:ZBH) had declared a cash dividend of $0.2400 on May 23, 2016. The shares will quote ex-dividend on Jun 22, 2016 and the record date has been fixed on Jun 24, 2016. At May 23, 2016 share price, the yield comes out to ...Zimmer Biomet Holdings, Inc. (NYSE:ZBH) topped earnings-per-share estimates 91% of the timeZergwatchZimmer Biomet Holdings Incorporated (NYSE:ZBH) Sellers Increased By 2.84% Their ShortsThe PostHealthcare Moving Stocks: Gilead Sciences, Inc. (NASDAQ:GILD) , Zimmer Biomet Holdings, Inc. (NYSE:ZBH)Is storiesShare Trading Newsall 5 news articles »
About Zimmer Biomet Holdings

Zimmer Biomet Holdings logoZimmer Biomet Holdings, Inc., formerly Zimmer Holdings, Inc., is engaged designing, manufacturing and marketing orthopaedic reconstructive products; sports medicine, biologics, extremities and trauma products; spine, bone healing, craniomaxillofacial and thoracic products; dental implants, and related surgical products. The Company's products and solutions helps treat patients suffering from disorders of, or injuries to, bones, joints, or supporting soft tissues. The Company manages its operations through three geographic operating segments: the Americas, consists of the United States and includes other North, Central and South American markets; EMEA, consists of Europe and includes the Middle East and African markets, and Asia Pacific, consists of Japan and includes other Asian and Pacific markets. Its four product category segments include Americas Spine, Bone Healing Craniomaxillofacial and Thoracic, and Dental.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: N/A
  • Exchange: NYSE
  • Symbol: ZBH
  • CUSIP:
Key Metrics:
  • Previous Close: $119.15
  • 50 Day Moving Average: $119.18
  • 200 Day Moving Average: $107.58
  • P/E Ratio: 292.96
  • P/E Growth: 1.34
  • Market Cap: $23.70B
  • Current Quarter EPS Consensus Estimate: $7.96 EPS
Additional Links:
Zimmer Biomet Holdings (NYSE:ZBH) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha